Rotterdam Criteria (2003)
International standard for PCOS diagnosis
What it is
The Rotterdam criteria are the international standard for diagnosing polycystic ovary syndrome (PCOS). They were established in 2003 at a joint consensus between ESHRE (European Society of Human Reproduction and Embryology) and ASRM (American Society for Reproductive Medicine).
PCOS is diagnosed when at least 2 of 3 criteria are present, after excluding other conditions that could explain the symptoms.
The 3 Rotterdam criteria
Criterion 1 — Oligo-anovulation
Irregular cycles (oligo-ovulation) or absent cycles (anovulation). In practice: fewer than 8 cycles per year, or cycles of highly variable length (> 35 days).
Criterion 2 — Clinical or biochemical hyperandrogenism
Either clinical: hirsutism assessed by the Ferriman-Gallwey score > 4-6, severe acne, androgenic alopecia. Or biochemical: elevated total or free testosterone, elevated DHEA-S or androstenedione.
Criterion 3 — Polycystic ovarian morphology (PCOM)
On pelvic ultrasound: ≥ 20 follicles of 2-9 mm per ovary (threshold updated in 2023) or ovarian volume ≥ 10 mL.
Mandatory exclusion conditions
PCOS can only be diagnosed after excluding conditions that can mimic its symptoms:
- Non-classic congenital adrenal hyperplasia (17-OH-progesterone)
- Cushing's syndrome (urinary free cortisol, dexamethasone suppression test)
- Hyperprolactinaemia (prolactin, pituitary MRI if needed)
- Androgen-secreting tumours
- Thyroid dysfunction (TSH)
The 4 phenotypes defined by Rotterdam
Depending on which criteria are present, 4 phenotypes are identified, each with distinct clinical and metabolic profiles:
- Phenotype A (full classic): OA + HA + PCOM
- Phenotype B (classic without PCOM): OA + HA
- Phenotype C (ovulatory): HA + PCOM (regular cycles)
- Phenotype D (normo-androgenic): OA + PCOM (without hyperandrogenism)
Learn more: PCOS phenotypes A/B/C/D.
ESHRE 2023 update
The 2023 ESHRE guidelines maintained the Rotterdam criteria as the standard while updating the PCOM threshold (AFC ≥ 20 instead of ≥ 12 follicles per ovary). They also introduced AMH as a potential marker for the morphological criterion in settings with calibrated laboratories.
Key takeaways
- 2 of 3 criteria required for diagnosis
- Criterion 1: oligo-anovulation
- Criterion 2: hyperandrogenism (clinical or biochemical)
- Criterion 3: PCOM (≥ 20 follicles/ovary or volume ≥ 10 mL)
- After exclusion of differential diagnoses
- International standard — updated ESHRE 2023